Hjarta Care, LLC
Company Details
Status: Private
Employees: 1-10
Location:
Waukesha, Wisconsin, United States
Type:
sample
Technology:
sample
About: To design a tool for surgical explant of endografts.
Consider; 80% of AAA patients receive EVAR, the minimally invasive option for repair. Getting a quality result quickly and efficiently is most assuredly part of the goal for both the patient and physician. At some point, 5+% of EVAR grafts are explanted due to failure or infection.
Our goal: develop a simple device for open surgical explant of an endovascular stent graft. At Hjärta Care we believe minimally invasive surgery should not just be the goal at implant. We believe the explant should be as atraumatic and painless as possible for both the patient and vascular surgeon. We discovered, through interviews and search of the clinical literature, that the syringe technique, orthopedic wire cutters, etc. were woefully inadequate in achieving a SAFE explant. In 2022 Hjärta Care received a patent for the XgraftR, a tool specifically designed for the removal of endovascular stent grafts during open surgical explant. This unique patented design allows for a simple and elegant explant, minimizing supra visceral cross clamp time and damage to the aortic intima.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Hjarta Care, LLC | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.